Merck (MRK) Current Deferred Tax Assets (2009 - 2023)

Merck (MRK) has reported Current Deferred Tax Assets for 15 consecutive years, with $6.6 billion the latest figure, recorded in Q2 2023.

• On a quarterly basis, Current Deferred Tax Assets fell 2.51% year-over-year to $6.6 billion in Q2 2023; TTM through Jun 2023 was $6.6 billion, a 2.51% decrease from a year earlier, with the FY2022 full-year figure at $7.2 billion, up 2.6% from the prior year.
• Current Deferred Tax Assets was $6.6 billion for Q2 2023 at Merck, down from $6.7 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $7.2 billion in Q3 2022 and troughed at $3.2 billion in Q1 2019.
• A 5-year average of $5.6 billion and a median of $6.0 billion in 2021 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets decreased 21.38% in 2019 and surged 49.49% in 2021, its largest moves.
• Over 5 years, Current Deferred Tax Assets stood at $4.3 billion in 2019, then gained by 9.28% to $4.7 billion in 2020, then surged by 49.49% to $7.0 billion in 2021, then grew by 2.6% to $7.2 billion in 2022, then declined by 7.39% to $6.6 billion in 2023.
• The last three Current Deferred Tax Assets figures came in at $6.6 billion (Q2 2023), $6.7 billion (Q1 2023), and $7.2 billion (Q4 2022), per Business Quant data.